Serum markers related to liver damage in CHC patients.
- Pamela Valva (105271)
- Paola Casciato (105274)
- Carol Lezama (105276)
- Marcela Galoppo (105279)
- Adrián Gadano (105281)
- Omar Galdame (105283)
- María Cristina Galoppo (105285)
- Eduardo Mullen (105286)
- Elena De Matteo (105288)
- María Victoria Preciado (105290)
Publication date
January 2013
DOIAbstract
<p>a) fibrosis, b) hepatitis and c) steatosis severity. Fibrosis stages according METAVIR. Significant fibrosis (F≥2) and advanced fibrosis (F≥3). * p<0.05;·<sup>#</sup> trend of association p<0.08.</p
Add to ORKG